Extent of Coronary Artery Disease in Patients With Stenotic Bicuspid Versus Tricuspid Aortic Valves
- PMID: 34075785
- PMCID: PMC8477872
- DOI: 10.1161/JAHA.120.020080
Extent of Coronary Artery Disease in Patients With Stenotic Bicuspid Versus Tricuspid Aortic Valves
Abstract
Background Bicuspid aortic valve (BAV) is the most common congenital cardiac malformation, which is often complicated by aortic valve stenosis (AoS). In tricuspid aortic valve (TAV), AoS strongly associates with coronary artery disease (CAD) with common pathophysiological factors. Yet, it remains unclear whether AoS in patients with BAV is also associated with CAD. This study investigated the association between the aortic valve morphological features and the extent of CAD. Methods and Results A single-center study was performed, including all patients who underwent an aortic valve replacement attributable to AoS between 2006 and 2019. Coronary sclerosis was graded on preoperative coronary angiographies using the coronary artery greater even than scoring method, which divides the coronaries in 28 segments and scores nonobstructive (20%-49% sclerosis) and obstructive coronary sclerosis (>49% sclerosis) in each segment. Multivariate analyses were performed, controlling for age, sex, and CAD risk factors. A total of 1296 patients (931 TAV and 365 BAV) were included, resulting in 548 matched patients. Patients with TAV exhibited more CAD risk factors (odds ratio [OR], 2.66; 95% CI, 1.79-3.96; P<0.001). Patients with BAV had lower coronary artery greater even than 20 (1.61±2.35 versus 3.60±2.79) and coronary artery greater even than 50 (1.24±2.43 versus 3.37±3.49) scores (P<0.001), even after correcting for CAD risk factors (P<0.001). Patients with TAV more often needed concomitant coronary revascularization (OR, 3.50; 95% CI, 2.42-5.06; P<0.001). Conclusions Patients with BAV who are undergoing surgery for AoS carry a lower cardiovascular risk profile, correlating with less coronary sclerosis and a lower incidence of concomitant coronary revascularization compared with patients with TAV.
Keywords: aortic valve replacement; aortic valve stenosis; bicuspid aortic valve; coronary artery disease.
Conflict of interest statement
None.
Figures


Similar articles
-
Comparative evaluation of coronary disease burden: bicuspid valve disease is not atheroprotective.Open Heart. 2021 Sep;8(2):e001772. doi: 10.1136/openhrt-2021-001772. Open Heart. 2021. PMID: 34497063 Free PMC article.
-
Impact of Valve Morphology on the Prevalence of Coronary Artery Disease: A Systematic Review and Meta-Analysis.J Am Heart Assoc. 2016 May 18;5(5):e003200. doi: 10.1161/JAHA.116.003200. J Am Heart Assoc. 2016. PMID: 27194004 Free PMC article.
-
Ascending aortic dilatation is rarely associated with coronary artery disease regardless of aortic valve morphology.J Thorac Cardiovasc Surg. 2014 Dec;148(6):2973-80.e1. doi: 10.1016/j.jtcvs.2014.08.023. Epub 2014 Aug 17. J Thorac Cardiovasc Surg. 2014. PMID: 25242056
-
Comparative study of bicuspid vs. tricuspid aortic valve stenosis.Eur Heart J Cardiovasc Imaging. 2018 Jan 1;19(1):3-8. doi: 10.1093/ehjci/jex211. Eur Heart J Cardiovasc Imaging. 2018. PMID: 29029001
-
Safety and efficacy of transcatheter aortic valve implantation in stenotic bicuspid aortic valve compared to tricuspid aortic valve: a systematic review and meta-analysis.Expert Rev Cardiovasc Ther. 2022 Jul;20(7):581-588. doi: 10.1080/14779072.2022.2094368. Epub 2022 Jul 5. Expert Rev Cardiovasc Ther. 2022. PMID: 35770517
Cited by
-
Normal and abnormal development of the aortic valve and ascending aortic wall: a comprehensive overview of the embryology and pathology of the bicuspid aortic valve.Ann Cardiothorac Surg. 2022 Jul;11(4):380-388. doi: 10.21037/acs-2021-bav-14. Ann Cardiothorac Surg. 2022. PMID: 35958528 Free PMC article. Review.
-
Comparative evaluation of coronary disease burden: bicuspid valve disease is not atheroprotective.Open Heart. 2021 Sep;8(2):e001772. doi: 10.1136/openhrt-2021-001772. Open Heart. 2021. PMID: 34497063 Free PMC article.
-
Aortic root replacement for bicuspid aortic valve dysfunction does not impair survival rates.J Cardiothorac Surg. 2024 Oct 1;19(1):560. doi: 10.1186/s13019-024-03061-7. J Cardiothorac Surg. 2024. PMID: 39354581 Free PMC article.
-
Commentary: Transforming growth factor serum concentrations in patients with proven non-syndromic aortopathy.Front Cardiovasc Med. 2023 Feb 2;10:1097201. doi: 10.3389/fcvm.2023.1097201. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36818342 Free PMC article. No abstract available.
-
The role of transforming growth factor beta in bicuspid aortic valve aortopathy.Indian J Thorac Cardiovasc Surg. 2023 Dec;39(Suppl 2):270-279. doi: 10.1007/s12055-023-01513-8. Epub 2023 May 25. Indian J Thorac Cardiovasc Surg. 2023. PMID: 38093932 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous